PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
PRISMA для рефератов: представление систематических обзоров в журнальных и конференционных рефератах
2013-04-09
SCID: 54.1/vbvp6kf8
Discuss with AI
PRISMA for Abstractsconference abstractsjournal abstractsreporting guidelinessystematic reviews
Figures from the paper
Abstract (AI)
Elaine Beller and colleagues from the PRISMA for Abstracts group provide a reporting guidelines for reporting abstracts of systematic reviews in journals and at conferences.
Key Findings
1
The PRISMA for Abstracts group provides reporting guidelines specifically for systematic review abstracts.
2
The guidelines are intended for abstracts published in journals and presented at conferences.
3
The work addresses standardized reporting of systematic review information within abstract formats.
Research Object
abstracts of systematic reviews in journals and at conferences
Research Subject
reporting of systematic reviews in abstracts
Publication Details
Publication Date
2013-04-09
Journal
Publisher
ISSN
Cited by
705
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials2011
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration2009
Consensus development methods, and their use in clinical guideline development.1998
Cited by6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation2018
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation2015
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews2021
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies2018
Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world2019